The subcellular expression patterns of FKBP10 (p < 0.001), along with the TNM stage (p < 0.001), differentiation grade (p < 0.001), chemotherapy (p < 0.05), tumor location (p < 0.05), serum CEA (p < 0.001) and serum CA19-9 (p < 0.001) were significantly associated with the DFS of patients via univariate Cox analysis. Here, FKBP10 is linked to neoplasm.